Safety and Tolerability of Adjuvant Topical Tacrolimus Treatment in Boys with Lichen Sclerosus: A Prospective Phase 2 Study

European Urology

Volumn 54, Issue 4, 2008, Pages 932-937

  Ebert, Anne K ^a   Rösch, Wolfgang H ^a   Vogt, Thomas ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Balanitis sclerotica obliterans; BXO; Childhood; Lichen sclerosus et atrophicus; Relapse; Tacrolimus ointment; Topical therapy

Indexed keywords

CLOBETASONE BUTYRATE; CORTISONE; TACROLIMUS;

ADOLESCENT; ARTICLE; BURN; CIRCUMCISION; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG SAFETY; DRUG TOLERABILITY; ERYTHEMA; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPOSPADIAS; LICHEN SCLEROSUS ET ATROPHICUS; MAJOR CLINICAL STUDY; MALE; MICTURITION; PHASE 2 CLINICAL TRIAL; PHIMOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PRURITUS; RECURRENT DISEASE; RISK FACTOR; SCHOOL CHILD; STENOSIS; SYMPTOMATOLOGY; TREATMENT FAILURE; URINE FLOW RATE;

ADMINISTRATION, TOPICAL; ADOLESCENT; CHEMOTHERAPY, ADJUVANT; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LICHEN SCLEROSUS ET ATROPHICUS; MALE; PROSPECTIVE STUDIES; TACROLIMUS;

EID: 50849138506     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2008.03.013     Document Type: Article

References (17)

1. Das S., and Tunuguntla H.S. Balanitis xerotica obliterans-a review. World J Urol 18 (2000) 382-387
2. Depasquale I., Park A.J., and Bracka A. The treatment of balanitis xerotica obliterans. BJU Int 86 (2000) 459-464
3. Gargollo P.C., Kozakewich H.P., Bauer S.B., et al. Balanitis xerotica obliterans in boys. J Urol 174 (2005) 1409-1412
4. Mattioli G., Repetto P., Carlini C., Granata C., Gambini C., and Jasonni V. Lichen sclerosus et atrophicus in children with phimosis and hypospadias. Pediatr Surg Int 18 (2002) 273-275
5. Powell J., Wojnarowska F., Winsey S., Marren P., and Welsh K. Lichen sclerosus premenarche: autoimmunity and immunogenetics. Br J Dermatol 142 (2000) 481-484
6. Meffert J.J., Davis B.M., and Grimwood R.E. Lichen sclerosus. J Am Acad Dermatol 32 (1995) 393-416
7. Hennge U.R., Krause W., Hofmann H., et al. Multicentre, phase II trial on safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosus. Br J Dermatol 155 (2006) 1021-1028
8. Ginarte M., and Toribio J. Vulvar lichen sclerosus successfully treated with topical tacrolimus. Eur J Obstet Gynecol Reprod Biol 123 (2005) 123-124
9. Ebert A.K., Vogt T., and Rösch W.H. Die topische Therapie der Balanitis xerotica obliterans (BXO) im Kindesalter: Klinische Langzeitergebnisse und Übersicht. Urologe 46 (2007) 1682-1686
10. Böhm M., Frieling U., Luger A., and Bonsmann G. Successful treatment of anogenital lichen sclerosus with topical tacrolimus. Arch Dermatol 139 (2003) 922-924
11. Rallis E., Korfitis C., Gregoriou S., and Rigopoulos D. Assigning new roles to topical tacrolimus. Expert Opin Investig Drugs 16 (2007) 1267-1276
12. Clemmensen O.J., Krogh J., and Petri M. The histologic spectrum of prepuces from patients with phimosis. Am J Dermatopathol 10 (1988) 104-108
13. McLelland J. Lichen sclerosus in children. J Obstet Gynaecol 24 (2004) 733-735
14. Meuli M., Birner J., Hanimann B., and Sacher P. Lichen sclerosus et atrophicus causing phimosis in boys: a prospective study with 5-year follow-up after complete circumcision. J Urol 152 (1994) 987-989
15. Herschorn S., and Colapinto V. Balanitis xerotica obliterans involving anterior urethra. Urology 14 (1979) 592-596
16. Vincent M.V., and Mackinnon E. The response of clinical balanitis xerotica obliterans to the application of topical steroid-based creams. J Pediatr Surg 40 (2005) 709-712
17. Fischer G., and Rogers M. Treatment of childhood vulvar lichen sclerosus with potent topical corticosteroid. Pediatr Dermatol 14 (1997) 235-238